In the Emergency Room rectal temperature was 105 degrees, pulse was 112, blood pressure 108/56 and she was satting 97% on 2 liters.
CT of the head was negative.
Chest x-ray was negative.
EKG also was negative.
PHYSICAL EXAMINATION:  The patient on exam had temperature of 105, pulse 112, blood pressure 108/56, oxygen saturation 97% on two liters.
Her mucus membranes were dry.
She had 2+ dorsalis pedis pulses bilaterally.
Her foot reflexes had 2+ knee jerks and 2+ biceps and toes were mute bilaterally.
LABORATORY DATA:  White blood cell count 9.6 with 81% polys, 16% lymphs, 3% monos, hematocrit 37.1, sodium 134, potassium 4.5, chloride 97, CO2 19, BUN 23, creatinine 1.4 (baseline 1.1 in [**2135-5-30**]), glucose 251, PTT 26.2, INR 1.4.
Urinalysis revealed large blood, no nitrates, greater than 300 protein, greater than 250 glucose, greater than 80 ketones, and 0-2 white blood cells.
Her ALT was 105, AST 427, amylase was 91 and total bilirubin was 0.9.
Her CK on admission was 27,862 with an MB total of 26 and troponin was 0.5.
Chest x-ray suggested a question of infiltrate at the right base.
An EKG revealed sinus tachycardia at a rate of 113 beats per minute with a normal axis and normal intervals.
An MRI of the head in addition to the CT of the head was negative.
Her Sinemet dosing was changed to Sinemet CR 50/200 q a.m., q noon and q 5 p.m. and regular Sinemet 25/100 q a.m.  She was also put on Pergolide 1 mg po q 8 hours and Eldepryl 5 mg at 7 a.m. and 12:30 p.m.
Her temperature improved with IV fluids and Dantrolene.
Rhabdomyolysis:  The patient initially presented with a CK of 27,862 and peaked at CK of 32,920.
Her MB fraction was consistently negative and troponins were negative.
Infectious Disease:  The patient was initially treated with Flagyl for question of aspiration pneumonia, however, the patient's white blood cell count remained normal and the patient's temperature also normalized and her lung exam was clear, therefore the Flagyl was discontinued.
Increased liver function tests:  There were felt to be secondary to shock liver and/or Tasmar and Dantrolene which were subsequently discontinued.
Her liver function tests improved prior to discharge.
[**MD Number(1) 3091**]  Dictated By:[**Last Name (NamePattern1) 11548**]  MEDQUIST36  D:  [**2136-12-8**]  07:38 T:  [**2136-12-9**]  22:04 JOB#:  [**Job Number **]
